Captopril and hydrochlorotiazide

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved May 1997

Specific Treatments:


General Information

Captopril and hydrochlorothiazide tablets have been tentatively approved for the treatment of hypertension. Tablets will be manufactured in 25mg/15mg, 50mg/15mg, 25mg/25mg and 50mg/25mg strengths. This antihypertensive product is the generic equivalent of Bristol-Myers Squibb’s capozide. Shipment is scheduled to begin after the Dec. 27, 1997 expiration of Bristol-Myers Squibb’s patent.


[ Home | Discussions | Article Archives | Help | Submit your Site]

Copyright 1996 - 2014 by Gelber Associates All Rights Reserved.